
From Lab to Launch by Qualio
December 15, 2021
About this episode
You may have heard the adage, "an ounce of prevention is worth a pound of cure." Today's guest Joseph Mocanu, PhD shares how companies and entrepreneurs across the world are overcoming barriers to bring an ounce of prevention to emerging markets and rural communities. His company, Verge HealthTech Fund focuses on seed stage healthcare technology companies relevant to emerging markets.
He explains how each of us can get involved and be part of the solution to bridge the gap in life sciences between human capital and healthcare access. We each can make a difference.
Joseph Mocanu is the Founder of Verge HealthTech Fund. Prior to this, Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia. He has 19 scientific publications, 3 patents, and has made investments in 23 healthcare technology companies to date. Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.
Show notes:
Verge HealthTech Fund: https://www.vergehc.com/Joseph on LinkedIn: https://www.linkedin.com/in/jmocanu/Other podcasts from Joseph: https://www.podfol.io/profile/joseph-mocanu/Qualio: qualio.com
Music by keldez
Existing Podcast Guesting Pro clients only. Contact your Outreach Manager for access.
Latest episodes
Key topics

UVC: Joseph Mocanu from Verge HealthTech Fund on interesting innovations in healthcare tech, 3 strategies that startups can use to ace fundraising and why it’s important for startups to do competitor analysis well
Understanding VC
May 2022